Mortality among Patients on Hemodialysis Who Received Heterologous and Homologous COVID-19 Vaccine Regimens in Thailand

被引:0
|
作者
Pattharanitima, Pattharawin [1 ]
Anumas, Suthiya Anumas [1 ]
Rattanasompattikul, Manoch [2 ]
Srithongkul, Thatsaphan [3 ]
Raksasuk, Sukit [3 ]
Sritippayawan, Suchai [3 ]
机构
[1] Thammasat Univ Hosp, Khlong Nueng, Pathum Thani, Thailand
[2] Golden Jubilee Med Ctr, Nakhon Pathom, Thailand
[3] Mahidol Univ, Fac Med, Siriraj Hosp, Bangkok, Thailand
来源
关键词
D O I
10.1681/ASN.20242t6bww5z
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
TH-PO1134
引用
收藏
页数:2
相关论文
共 50 条
  • [1] HETEROLOGOUS VERSUS HOMOLOGOUS TRIPLE ANTI-COVID-19 VACCINE REGIMENS IN PATIENTS ON MAINTENANCE HEMODIALYSIS
    Meijers, Bjorn
    Goedgezelschap, Annelien
    Peeters, Domien
    van der Veen, Annelien
    Verbinnen, Margo
    Vermeersch, Pieter
    Stas, Koenraad J. F.
    Kuypers, Dirk
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2022, 37 : I637 - I637
  • [2] Heterologous vaccine regimens against COVID-19
    Duarte-Salles, Talita
    Prieto-Alhambra, Daniel
    LANCET, 2021, 398 (10295): : 94 - 95
  • [3] Update to living systematic review on effectiveness of heterologous and homologous covid-19 vaccine regimens
    Mathioudakis, A. G.
    BMJ-BRITISH MEDICAL JOURNAL, 2022, 379
  • [4] MORTALITY AMONG CRITICALLY ILL PATIENTS WITH COVID-19 WHO RECEIVED TOCILIZUMAB
    Kruer, Rachel
    Tran, Mya
    Pollander, Abby
    Fadel, William
    Desai, Armisha
    CRITICAL CARE MEDICINE, 2022, 50 (01) : 111 - 111
  • [5] Safety and Immunogenicity of Homologous and Heterologous Adenoviral-Vectored and mRNA COVID-19 Vaccine Regimens in Radiotherapy Patients
    Prayongrat, Anussara
    Noppaving, Patjaya
    Chobarporn, Thitiporn
    Sudhinaraset, Natthinee
    Teeyapun, Nattaya
    Pakvisal, Nussara
    Jantarabenjakul, Watsamon
    Sophonphan, Jiratchaya
    Lertbutsayanukul, Chawalit
    Poovorawan, Yong
    VACCINES, 2023, 11 (07)
  • [6] Expected Usefulness of Fourth Dose of COVID-19 Vaccine for Patients with Underlying Solid Tumor who Previously Received the Primary Heterologous COVID-19 Vaccine
    Yasri, Sora
    Wiwanitkit, Viroj
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2024, 45 (04) : 301 - 305
  • [7] Durability of Heterologous and Homologous COVID-19 Vaccine Boosts
    Tan, C. Sabrina
    Collier, Ai-ris Y.
    Yu, Jingyou
    Liu, Jinyan
    Chandrashekar, Abishek
    McMahan, Katherine
    Jacob-Dolan, Catherine
    He, Xuan
    Roy, Vicky
    Hauser, Blake M.
    Munt, Jennifer E.
    Mallory, Michael L.
    Mattocks, Melissa
    Powers, John M.
    Meganck, Rita M.
    Rowe, Marjorie
    Hemond, Rachel
    Bondzie, Esther A.
    Jaegle, Kate H.
    Baric, Ralph S.
    Schmidt, Aaron G.
    Alter, Galit
    Le Gars, Mathieu
    Sadoff, Jerald
    Barouch, Dan H.
    JAMA NETWORK OPEN, 2022, 5 (08) : E2226335
  • [8] Mortality and severity among Covid-19 patients who already vaccinated with inactivated Covid-19 vaccine
    Tanod, D. V.
    Abdurrahmanto, A.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2022, 186
  • [9] Safety profiles of homologous and heterologous regimens containing three major types of COVID-19 vaccine among people living with HIV
    Khawcharoenporn, Thana
    Hanvivattanakul, Sirashat
    INTERNATIONAL JOURNAL OF STD & AIDS, 2024, 35 (04) : 262 - 273
  • [10] Heterologous versus homologous triple anti-COVID-19 vaccine regimens in patients on maintenance haemodialysis
    Meijers, Bjorn
    Goedgezelschap, Annelien
    Peeters, Domien
    Van der Veen, Annelien
    Verbinnen, Margo
    Vermeersch, Pieter
    Stas, Koen
    Kuypers, Dirk
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2022, 37 (07) : 1384 - 1386